ASURAGEN INC

Profile

Company Names

ASURAGEN INC

Addresses

2150 WOODWARD STREET, SUITE 100, AUSTIN, TX 78744

2150 WOODWARD ST SUITE 100, AUSTIN, TX 78744

Phone Numbers

(512) 681-5200
512-681-5200

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$12,500,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2013-03-07 
$7,500,000.00 
$15,000,000.00 
$7,500,000.00 
Equity 
1
2011-07-29 
$5,000,000.00 
$10,000,000.00 
$5,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
LYLE 
 
ARNOLD 
DIRECTOR
ASURAGEN INC   |  BIOCEPT INC
CAROL 
 
BERRY 
EXECUTIVE OFFICER
ASURAGEN INC
ROLLAND 
 
CARLSON 
EXECUTIVE OFFICER, DIRECTOR
ASURAGEN INC   |  PRISTINE, INC.
ROBERT 
J 
DOMINICI 
DIRECTOR
ASURAGEN INC
CHRISTOPHER 
D 
EARL 
DIRECTOR
ASURAGEN INC   |  MIRNA THERAPEUTICS, INC.
LYNNE 
 
HOHLFELD 
EXECUTIVE OFFICER
ASURAGEN INC   |  MIRNA THERAPEUTICS, INC.
EVAN 
S 
MELROSE 
DIRECTOR
ASURAGEN INC   |  MIRNA THERAPEUTICS, INC.
JOHN 
E 
MOONEY 
DIRECTOR
ASURAGEN INC
DAVID 
 
RUBIN 
DIRECTOR
AVIIR INC   |  DAKTARI DIAGNOSTICS, INC.   |  VIRTUALSCOPICS, INC.   |  ASURAGEN INC   |  CULURU CONSULTING LTD.   |  NAVIGATING CANCER, INC.   |  OJO LABS INC.   |  ELECTROCORE, LLC   |  OPCITY INC.   |  HAWK HOLDING COMPANY, LLC   |  S BRAND L.L.C.   |  OJO HOLDINGS CORP.   |  LOCALS TECHNOLOGY INC.   |  HEALTHTECH SOLUTIONS, INC./UT   |  SCP GALILEO INVESTORS, LLC   |  SCP NEWTON INVESTORS, LLC   |  STRATA ONCOLOGY, INC.
DAVID 
 
SARGENT 
DIRECTOR
ASURAGEN INC
ANA 
 
WARD 
EXECUTIVE OFFICER
ASURAGEN INC   |  MIRNA THERAPEUTICS, INC.
MATTHEW 
M 
WINKLER 
EXECUTIVE OFFICER, DIRECTOR
ASURAGEN INC   |  MIRNA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2013-03-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-03-07 
2011-08-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-07-29 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#